Coral Laboratories Ltd


BSE: 524506 | NSE: NA | ISIN: INE683E01017 
Market Cap: [Rs.Cr.] 22 | Face Value: [Rs.] 10
Industry: Pharmaceuticals - Indian - Formulations

 Discuss this stock

Profit & Loss

(Rs. in Crores)
ParticularsMar-12Mar-11Mar-10Mar-09Mar-08Mar-07
INCOME :      
Sales Turnover 40.7433.2634.7535.0634.4035.20
Excise Duty0.780.560.760.581.754.77
Net Sales39.9632.7033.9934.4832.6530.43
Other Income 0.890.630.840.940.430.04
Stock Adjustments -0.22-0.13-0.51-0.470.920.16
Total Income40.6333.2034.3234.9534.0030.63
EXPENDITURE :      
Raw Materials 15.2611.4319.0520.1519.4816.96
Power & Fuel Cost1.150.840.900.990.850.61
Employee Cost 3.643.493.133.653.802.53
Other Manufacturing Expenses 9.948.191.000.950.970.73
Selling and Administration Expenses 1.231.361.691.862.361.73
Miscellaneous Expenses 0.941.211.151.121.130.79
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure32.1526.5126.9228.7228.5923.35
Operating Profit8.486.697.406.235.417.28
Interest 0.120.180.461.101.220.53
Gross Profit8.366.516.945.134.196.75
Depreciation1.271.261.241.201.010.72
Profit Before Tax7.095.255.703.933.186.03
Tax1.381.050.990.490.360.36
Fringe Benefit tax0.000.000.000.050.040.03
Deferred Tax0.060.040.040.020.000.02
Reported Net Profit5.654.164.673.372.785.62
Extraordinary Items 0.000.000.000.000.000.00
Adjusted Net Profit5.654.164.673.372.785.62
Adjst. below Net Profit 0.000.000.000.000.000.00
P & L Balance brought forward26.5923.3519.6117.0414.9810.29
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.970.920.930.800.720.93
P & L Balance carried down31.2726.5923.3519.6117.0414.98
Dividend0.540.540.540.430.360.54
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %15.0015.0015.0012.0010.0015.00
Earnings Per Share-Unit Curr15.5711.4012.839.247.6215.49
Earnings Per Share(Adj)-Unit Curr15.5711.4012.839.247.6215.49
Book Value-Unit Curr106.8392.7582.8371.5163.4756.86

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Ajanta Pharma 2,197.50 21.73 6.17 5.40 27.3 24.2 0.72
Plethico Pharma. 688.21 59.76 1.26 33.34 -5.5 3.8 1.08
Sharon Bio-Med. 364.00 7.06 1.99 9.58 19.1 14.1 1.85
Bliss GVS Pharma 327.34 5.58 1.56 2.15 28.0 42.7 0.04
Venus Remedies 321.36 5.62 0.83 3.54 17.7 16.9 0.72
Parenteral Drugs 280.56 0.00 1.11 58.93 -16.1 -0.7 0.86
Syncom Formul. 274.96 79.04 3.29 13.86 4.3 6.7 0.09
Kappac Pharma 250.89 0.00 10.46 0.00 0.0 0.0 0.06
Ahlcon Parent(I) 248.40 19.30 4.59 22.59 12.6 17.0 0.59
Amrutanjan Healt 199.44 16.97 2.00 9.89 12.6 16.3 0.23
Arvind Remedies 161.09 3.97 1.19 6.60 15.1 16.1 2.12
Zenotech Lab. 109.83 0.00 2.13 0.00 0.0 0.0 0.08
Caplin Point Lab 99.12 6.38 3.27 1.38 29.3 33.1 0.30
Combat Drugs 95.20 0.00 16.46 0.00 0.3 0.3 0.07
Hester Bios 91.53 11.26 1.52 4.56 14.4 20.6 0.35

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

Navin B Doshi , Chairman 

Priyush R Dhedhi , Director 

Kishor R Mehta , Executive Director 

Samir A Sheth , Director 


Company Head Office / Quarters:
308/5 Vill & Post Poicha (Ran),
Savli Taluka,
Baroda,
Gujarat-390780
Phone : 91-02667-244312/244313/244314
Fax : 91-02667-244313
E-mail :
murthy@corallab.com
factory@corallab.com
Web : http://www.corallab.com
Registrars:
Link Intime India Pvt Ltd
C-13 Pannalal Silk
Mills Cmpd LBS Marg
Bhandup West
Mumbai - 400 078

Fund Holding

 
Scheme Name No. of Shares
No data found

Calendar

May-2013
M T W T F S S
20 21 22 23 24 25 26
IPO
listIssue Open : Just Dial
listIssue Closing : Onesource Techm.
Economic Events
list Adjusted Merchandise Trade Balance (Yen)
list Merchandise Trade Balance Total (Yen)
Results
list Tech Mahindra